Skip to main content
SCI Pharmtech, Inc. logo

SCI Pharmtech, Inc. — Investor Relations & Filings

Ticker · 4119 ISIN · TW0004119003 TW Manufacturing
Filings indexed 1,696 across all filing types
Latest filing 2025-12-18 Regulatory Filings
Country TW Taiwan
Listing TW 4119

About SCI Pharmtech, Inc.

https://www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.

Recent filings

Filing Released Lang Actions
114年第3季財務報告書 — 202503_4119_AIA.pdf
Regulatory Filings
2025-12-18 Chinese
114年第3季財務報告書 — 202502_4119_AI1.pdf
Regulatory Filings
2025-12-18 Chinese
114年第3季財務報告書 — 202501_4119_AIA.pdf
Regulatory Filings
2025-12-18 Chinese
114年第3季財務報告書 — 202501_4119_AI1.pdf
Regulatory Filings
2025-12-18 Chinese
114年11月背書保證與資金貸與
Regulatory Filings
2025-12-08 Chinese
114年11月營業收入
Regulatory Filings
2025-12-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.